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Abstract Genetic evidence indicates that the major gel-
atinases MMP-2 and MMP-9 are involved in mammalian
craniofacial development. Since these matrix metallopro-
teinases are secreted as proenzymes that require activation,
their tissue distribution does not necessarily reflect the sites
of enzymatic activity. Information regarding the spatial and
temporal expression of gelatinolytic activity in the head
of the mammalian embryo is sparse. Sensitive in situ
zymography with dye-quenched gelatin (DQ-gelatin) has
been introduced recently; gelatinolytic activity results in a
local increase in fluorescence. Using frontal sections of
wild-type mouse embryo heads from embryonic day
14.5–15.5, we optimized and validated a simple double-
labeling in situ technique for combining DQ-gelatin
zymography with immunofluorescence staining. MMP
inhibitors were tested to confirm the specificity of the
reaction in situ, and results were compared to standard
SDS-gel zymography of tissue extracts. Double-labeling
was used to show the spatial relationship in situ between
gelatinolytic activity and immunostaining for gelatinases
MMP-2 and MMP-9, collagenase 3 (MMP-13) and MT1-
MMP (MMP-14), a major activator of pro-gelatinases.
Strong gelatinolytic activity, which partially overlapped
with MMP proteins, was confirmed for Meckel’s cartilage
and developing mandibular bone. In addition, we combined
in situ zymography with immunostaining for extracellular
matrix proteins that are potential gelatinase substrates.
Interestingly, gelatinolytic activity colocalized precisely
with laminin-positive basement membranes at specific sites
around growing epithelia in the developing mouse head,
such as the ducts of salivary glands or the epithelial fold
between tongue and lower jaw region. Thus, this sensitive
method allows to associate, with high spatial resolution,
gelatinolytic activity with epithelial morphogenesis in the
embryo.
Keywords Mouse embryo  Craniofacial development 
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Introduction
Extracellular matrix (ECM) remodeling is required for a
variety of physiological processes during development and
regeneration (Mott and Werb 2004). An important part of
ECM remodeling is accomplished by the family of matrix
metalloproteinases (MMPs), which counts at least 25
extracellular or membrane-bound members. MMPs are
produced as proenzymes and become active after cleavage
of their propeptide. Their main characteristic is the utili-
zation of a Zn2? metal ion to polarize a water molecule and
perform the hydrolysis reaction (Clark et al. 2010; Parks
et al. 2004). For years it was believed that the role of
MMPs in the organism was limited to ECM degradation.
However, a large number of non-matrix substrates have
been identified, such as cytokines, growth factors, and
proenzymes, indicating a much broader role of these
enzymes in tissue homeostasis and the regulation of
physiological and pathological processes (Aiken and
Khokha 2010; Butler and Overall 2009).
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MMP-2 and MMP-9 are the major proteases with gel-
atinolytic activity in the organism. They are secreted pro-
teins that can cleave a variety of ECM substrates but are
particularly efficient in degrading partially denatured
fibrillar collagens (‘‘gelatin’’). In addition, MMP-2 and -9
are involved in the degradation of native type IV collagen
as well as laminin, major components of basement mem-
branes (Odaka et al. 2005; Visse and Nagase 2003). Due to
their role in basement membrane turnover, the gelatinases
have gained special interest in studies on tumor invasion
and metastasis (Clark et al. 2010; Nelson et al. 2000).
However, they are also associated with a variety of bio-
logical processes such as bone remodeling (Martignetti
et al. 2001), angiogenesis (Deryugina and Quigley 2006),
immune response and inflammation (Merkle et al. 2010),
and tissue repair (Zhang et al. 2011). Moreover, from
genetic studies on both humans (Al Aqeel et al. 2000;
Lombardi et al. 2008) and mice (Egeblad et al. 2007;
Miettinen et al. 1999; Mosig et al. 2007; Robbins et al.
1999), there is strong evidence indicating that MMP-2 and
-9 activity is important for various aspects of craniofacial
development. In addition, there are reports that other
MMPs are important for head morphogenesis. For example
MMP-13 (collagenase-3), which besides fibrillar collagen
also efficiently cleaves gelatin and other ECM components
(Knauper et al. 1997), has been implicated in secondary
palate formation (Blavier et al. 2001). Similarly, mem-
brane-bound MMP-14 (MT1-MMP) has been shown to be
involved in this process (Shi et al. 2008), presumably
because it is required for activating pro-MMP-2 (Evans and
Itoh 2007).
The biological function of MMPs, including gelatinases,
is subjected to various levels of endogenous regulation:
gene transcription, enzyme synthesis and secretion, pro-
enzyme activation, and activity inhibition by endogenous
tissue factors, such as a2-macroglobulins or tissue inhibi-
tors of metalloproteinases (TIMPs) (Baker et al. 2002;
Nelson et al. 2000). Techniques used for quantification and
localization of mRNA or protein do not provide informa-
tion about the functional activity of MMPs. Therefore,
zymography techniques have been developed for the
analysis of enzymatic activity of MMPs in biological
samples.
Fig. 1 In situ zymography of craniofacial structures in the mouse
embryo using dye-quenched (DQ)-gelatin. a Frontal section of a
E14.5 wild-type mouse head stained with hematoxylin/eosin. The
boxed area illustrates the region of interest that is presented in b and
c, as well as in all following figures. b In situ zymography on an
unfixed cryosection of the region of interest, performed by adding
DQ-gelatin directly to the gelatinase reaction buffer (see ‘‘Materials
and methods’’). Prominent gelatinolytic activity, as manifested by
increased fluorescence, was detected in the marrow cavities of the
developing mandibular bone, in Meckel’s cartilage, around the ducts
of the salivary glands (arrows), and around the epithelial fold that
separates the tongue from the lower jaw region (arrowhead). c In situ
zymography of the same region as in b, except that the slide was
precoated with DQ-gelatin before adsorbing the tissue section, and no
substrate was added to the gelatinase reaction buffer. Note that this
technique produced a very similar fluorescence pattern as observed in
b, although with higher background. This indicates that the fluores-
cent signal generated in b was not due to differential binding of DQ-
gelatin to the section. E eye, FB forebrain, MB mandibular bone, MC
Meckel’s cartilage, NC nasal cavity, TB tooth buds, TN tongue. Bars
500 lm (a); 200 lm (b, c)
b
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Zymography on gelatin-containing SDS-polyacrylamide
gels is a well-established technique for the detection of
enzymes with gelatinolytic activity in bulk biological
samples (Frederiks and Mook 2004). Both the active and
latent forms of each specific enzyme can be detected,
identified according to their molecular weight, and quan-
tified. This is important since apart from MMP-2 and
MMP-9, several other proteinases can also cleave gelatin
(Snoek-van Beurden and Von den Hoff 2005). However,
because SDS disrupts the interactions between MMPs and
inhibitors such as TIMPs, it is impossible to detect the net
functional activity that is present in a sample (Ikeda et al.
2000; Woessner 1995). Moreover, SDS gel zymography
does not allow to determine the tissue location and cellular
origin of enzyme activity (Snoek-van Beurden and Von
den Hoff 2005).
During the last years, techniques for the in situ detection
of gelatinolytic activity on tissue sections have been
developed. One example is the in situ film zymography, a
low-cost technique that is relatively easy to perform but has
limited sensitivity and reproducibility (Abiko et al. 1999;
Ikeda et al. 2000; Mungall et al. 1998). Tissue sections are
overlaid with a gelatin-based photographic emulsion, and
after development a (usually) negative image results from
its digestion over areas with gelatinolytic activity. How-
ever, tissue structures cannot be observed in detail since
histology is obscured by the emulsion in undigested areas.
In situ zymography (ISZ) using an overlay of fluorescent
substrate is another option, but with similar limitations
(Frederiks and Mook 2004; Galis et al. 1995; Yan and
Blomme 2003).
A major advance occurred by introducing dye-quenched
(DQ) substrates, such as DQ-gelatin, into ISZ (Oh et al.
1999). Since such substrates are excessively labeled with
fluorescent dye, emitted photons are quenched by adjacent
fluorophores. Digestion results in spatial separation of fluo-
rophores and dequenching, causing an increase in fluores-
cence. Thus, areas with gelatinolytic activity are visualized
as highly fluorescent sites on a less intense background. This
method is more sensitive than other methods, and due to
uncompromised histology provides more detailed informa-
tion on the localization of gelatinolytic activity. Since its
introduction, it has been applied repeatedly with encourag-
ing results (Frederiks and Mook 2004; Porto et al. 2009;
Wang and Tsirka 2005; Yan and Blomme 2003).
Several protocols have been reported regarding ISZ with
DQ-gelatin substrates. Frederiks and Mook (2004) proposed
to use an overlay of 1 % w/v low gelling temperature
agarose containing DQ-gelatin for the in situ detection of
gelatinolytic activity in frozen unfixed sections. This pro-
tocol has been used to study craniofacial tissues (Sakakura
et al. 2007; Sakuraba et al. 2006). However, the difficulty to
produce an even gel layer may influence the reproducibility
and sensitivity of the method. For gelatin ISZ combined
with immunohistochemistry, Frederiks and Mook (2004)
suggested to perform first the antibody labeling on acetone-
fixed sections and then to proceed with ISZ. However, the
influence of acetone fixation on the sensitivity of the
zymography was not commented. In an alternative
approach, a solution of DQ-gelatin dissolved in incubation
buffer (without agarose) was placed directly on the section
(Clark et al. 2010; Nagel et al. 2004; Wang and Tsirka
2005). This opened the possibility to label with antibodies
after completion of ISZ (Clark et al. 2010; Wang and Tsirka
2005). Based on the latter approach, we devised a simple,
high resolution method for in situ detection of gelatinolytic
activity in combination with subsequent immunofluores-
cence labeling on frozen sections of mouse embryo heads.
We tested different protocols reported in the literature in
order to optimize sensitivity. The method was validated by
various types of control experiments with inhibitors, as well
as by supplementary techniques such as SDS gel zymog-
raphy. Frontal sections of the developing mouse head at
embryonic days E14.5 and E15.5 showing the region of
mandibular bone, Meckel’s cartilage, and tongue were
analyzed. Whereas gelatinolytic activity had been detected
before in Meckel’s cartilage and mandibular bone at a
similar stage (Sakakura et al. 2007), our optimized ISZ/
immunofluorescence double-labeling technique allowed for
the first time to colocalize activity with a subset of
embryonic basement membranes underneath growing
epithelia.
Materials and methods
Animals, embryonic tissue, and cryosectioning
C57BL/6 wild-type mouse embryos were obtained from
J.-F. Spetz at the Friedrich-Miescher Institute for Biomedical
Research (FMI) in Basel, Switzerland. After mating,
appearance of a vaginal plug was taken as embryonic day
0.5 (E0.5). Pregnant females were killed at the desired
stage (E14.5 or E15.5), embryos were removed from the
uterus and decapitated. All procedures were approved by
the Cantonal Veterinary Office of Basel, Switzerland. The
embryo heads were washed in ice-cold PBS, soaked and
embedded in Tissue Tek (O.C.T. compound; Sakura
Finetek Europe B.V., Zoeterwoude, The Netherlands), and
frozen on a metal block cooled to -80 C. Alternatively,
heads were fixed in 4 % paraformaldehyde in phosphate
buffered saline (PBS; 150 mM NaCl, 20 mM Na-phos-
phate, pH 7.4) overnight, washed briefly in PBS, soaked for
24 h in 30 % sucrose in PBS, embedded in Tissue Tek, and
frozen. All tissues were stored at -80 C before section-
ing. Serial frontal sections (10–12 lm thick) of the embryo
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heads were prepared on a Cryocut E cryomicrotome
(Reichert-Jung, Leica Microsystems, Heerbrugg, Switzer-
land), dried at 37 C for 1–5 min, and stored at -80 C
before further use.
Histology
For standard histology, cryosections prepared from form-
aldehyde-fixed tissue (see above) were stained with
hematoxylin/eosin (H&E). Slides were incubated in
Meyer’s hematoxylin solution (Merck, Zug, Switzerland)
for 2 min, immersed in 0.1 % HCl for 2 s, washed with tap
water for 5 min, stained with 0.5 % Eosin G/Y solution
(Merck) containing 0.2 % acetic acid for 3 min, washed
with tap water for 30 s, dehydrated in an ethanol series
followed by xylene, and embedded in Entellan (Merck).
In situ zymography
A brief description of the protocols tested for in situ
zymography (ISZ) is provided in Table 1A, and for ISZ
combined with immunofluorescence on the same section in
Table 1B. Fluorescein-conjugated, dye-quenched gelatin
from pig skin (DQTM-gelatin) was obtained from Molecular
Probes (Invitrogen, Basel, Switzerland). A 1 mg/ml stock
solution of DQ-gelatin was prepared in gelatinase reaction
buffer (150 mM NaCl, 5 mM CaCl2, 0.2 mM NaN3, 50 mM
Tris–HCl, pH 7.6) and stored at 4 C. Prior to storage and
Table 1 Brief description of the protocols tested on unfixed cryostat sections of E14.5 wild-type mouse heads
Substrate Application of substrate Incubation
period
Quality of the result
A. ISZ protocols tested
1. 100 lg/ml DQ-
gelatin ? 1 %
agarose
Application of the substrate over the sections using a glass
cylinder and a piece of parafilm to obtain an even substrate
layer, coverage with coverslips and incubation
24 h Non-specific signal, reduced
reproducibility, moderate
preservation of tissue structure
integrity
2. 50 or 100 lg/ml
DQ-
gelatin ? 1 %
agarose
As above ? extra ISZ buffer over the substrate prior to
coverage and incubation
6, 24 h As in protocol 1 ? bad preservation of
tissue structure integrity
3. 50 lg/ml DQ-
gelatin ? 1 %
agarose
Rinse and preincubation of slides with ISZ buffer for 30 min
and proceed as above
3 h As in protocol 2
4. 50 lg/ml DQ-
gelatin
As in protocol 1 0, 3, 34 h Specific signal, inhibition by EDTA &
Phen. Moderate preservation of
tissue structure integrity
5. 20 or 50 lg/ml
DQ-gelatin
Application of the substrate on the sections and proceed as
described in ‘‘Materials and methods’’
0, 1.5, 3,
24 h
Specific signal, inhibition/no signal by
all inhibitors/controls tested,
excellent preservation of tissue
structures
6. 20 lg/ml DQ-
gelatin
Use of slides precoated with 20 lg/ml DQ-gelatin substrate
and proceed as described in ‘‘Materials and methods’’
3 h Specific signal, good preservation of
tissue structures, high background
(inappropriate for high
magnification)
Technique for ISZ ? IF Quality of the result
B. ISZ ? IF protocols tested
IF ? 20 lg/ml DQ-gelatin As described in ‘‘Materials and methods’’
changing the sequence of methods applied and
without any fixation
Good IF signal, partially specific but much
reduced ISZ signal, moderate preservation of
tissue structure integrity
acetone ? IF ? 20 lg/ml DQ-gelatin As described in ‘‘Materials and methods’’, while
changing the sequence of methods applied
Good IF signal, partially specific but much
reduced ISZ signal, bad preservation of tissue
structure integrity
20 lg/ml DQ-gelatin ? IF As described in ‘‘Materials and methods’’,
without any fixation
Good IF signal, specific but moderate to good
ISZ signal, moderate preservation of tissue
structure integrity
20 lg/ml DQ-gelatin ? acetone ? IF As described in ‘‘Materials and methods’’ Good IF signal, good ISZ signal, excellent
preservation of tissue structure integrity
A. Detection of gelatinolytic activity by in situ zymography (ISZ) alone; B. ISZ and immunofluorescence (IF) on the same section (double staining)
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use, it is advisable to pass the stock solution of DQ-gelatin
through a sterile syringe filter (cellulose acetate, 0.2 lm pore
size) in order to remove all fluorescent precipitates. In the
standard procedure (Table 1A), the working solution for in
situ zymography was made by directly diluting DQ-gelatin
stock solution in reaction buffer to a final concentration of
20 lg/ml. Unfixed cryosections were thawed, rounded with
a wax pen, overlaid with 250 ll DQ-gelatin working solution
(for approximately half of the slide), and incubated at 37 C
in a dark wet chamber. For the standard ISZ protocol pro-
posed we concluded that 3 h of incubation is an ideal time for
providing adequate signal while differentiating optimally
between regions with higher or lower activity. After three
washes with PBS, sections were either processed for
immunofluorescence (see below), or mounted directly in
90 % glycerol in PBS containing 10 mg/ml propyl 3,4,5-
trihydroxybenzoate (Merck, Darmstadt, Germany) as anti-
fading agent. Sections could be stored at 4 C for at least
2 weeks without losing significant information. However, it
should be kept in mind that unless the sections are post-fixed
(see below), the gelatinolytic reaction may continue during
storage even at low temperature, leading to changes in the
fluorescent signal.
In certain experiments, empty slides were precoated
with 150 ll DQ-gelatin (20 lg/ml), and the solution was
allowed to dry for 10 min. Afterwards, slides were washed
with sterile H2O for 5 s and allowed to dry for 5 min.
These slides were then used to pick up sections prepared on
the cryomicrotome. For ISZ, sections on DQ-gelatin-pre-
coated slides were covered with 250 ll gelatinase reaction
buffer alone and processed as described above.
For negative controls, the DQ-gelatin was either omitted
from the gelatinase reaction buffer, or replaced by 20 lg/ml
unlabeled pig skin gelatin (Merck). The effects of 4 % para-
formaldehyde fixation as well as of adding 2 mg/ml of unla-
beled gelatin to the working DQ-gelatin solution were also
tested. Additional experiments were performed to control for
the specificity of the enzyme reaction. First, incubation was
done both at 4 and 37 C with three incubation time periods: 0,
1.5, and 3 h. Second, either of the following metalloproteinase
inhibitors was added to the DQ-gelatin working solution prior
to incubation of the slides: 10 mM ethylenediamine tetra-
acetic acid (EDTA; Merck; replacing CaCl2 in the reaction
buffer); 0.2–3 % dimethyl sulfoxide (DMSO; Sigma); 1 mM
1,10-phenanthroline (Phen; Sigma, Buchs, Switzerland); or
50 lM (2R)-[(4-biphenylsulfonyl)amino]-N-hydroxy-3-phe-
nylpropionamide (BiPS; MMP-2/MMP-9 inhibitor II;
Calbiochem/Merck Chemicals, Nottingham, UK).
Immunofluorescence staining
In early trials to combine ISZ with antibody labeling, we
followed a published protocol (Frederiks and Mook 2004)
in which immunofluorescence staining was done first on
acetone-fixed sections, before proceeding with ISZ. How-
ever, we observed that prior acetone fixation hampered the
gelatinolytic reaction, thus reducing the sensitivity of the
method (not shown). In the standard protocol (Table 1A),
we therefore started with ISZ on unfixed cryosections,
before fixing the zymography pattern and continuing with
immunolabeling (Table 1B). Cold acetone proved to be an
appropriate fixative with optimal performance for both
techniques; cross-linking fixatives such as paraformalde-
hyde had to be avoided since they reduced ISZ-generated
fluorescence and interfered with binding of certain anti-
bodies (not shown). Immediately after processing for ISZ
(see above), sections were fixed in cold acetone (-20 C)
for 1 min, then incubated with 3 % bovine serum albumin
in PBS (BSA/PBS) for 10 min, and then with primary
antibody diluted in BSA/PBS for 45 min at room temper-
ature. To block endogenous mouse IgG, sections to be
stained with mouse monoclonal antibody (see below) were
previously incubated with unlabeled goat-anti-mouse IgG
(1:50; Cappel/MP Biomedicals, Santa Ana, CA) in BSA/
PBS for 1 h. The following primary antibodies were used:
rabbit anti-horse serum fibronectin (1:200; Wehrle and
Chiquet 1990); rabbit anti-mouse EHS laminin (1:200;
Paulsson et al. 1987); rat monoclonal antibody mTn12
against mouse tenascin-C (hybridoma supernatant 1:10;
Aufderheide and Ekblom 1988); goat anti-mouse MMP-2
(1:20; R&D Systems, Abingdon, UK); goat anti-mouse
MMP-9 (1:20; R&D Systems); mouse monoclonal anti-
body against human MMP-13 (crossreacts with mouse
MMP-13; 10 lg/ml; R&D Systems); goat anti-human
MT1-MMP/MMP14 (1:20; R&D Systems). After three
washes in BSA/PBS, sections were covered for 30 min
with the respective secondary antibody (rhodamine-conju-
gated goat anti-rabbit or goat anti-rat IgG from Cappel/MP
Biomedicals, Santa Ana, CA; Cy3-conjugated mouse anti-
goat IgG from Jackson ImmunoResearch/Milan Analytica,
Rheinfelden, Switzerland; Alexa-Fluor 568 labeled goat
anti-mouse IgG from Molecular Probes/Invitrogen, Basel,
Switzerland) diluted 1:100 in BSA/PBS. After washing in
DEPC-treated H2O, slides were mounted in buffered
glycerol with anti-fading agent (see above).
Microscopy
Slides were viewed with 109 and 409 fluorescence
objectives on a Olympus BX-51 microscope equipped
with epifluorescence optics, using mirror units U-MWIBA3
for fluorescein (DQ-gelatin) and U-MWIGA3 for rhoda-
mine and Cy3 (secondary antibodies), respectively. Digi-
tal images were recorded using a ProgRes CT3 CMOS
camera and ProgRes Capture Pro software (Jenoptik, Jena,
Germany). For each objective, all slides from one experiment
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were photographed at exactly the same camera settings,
and resulting images were processed identically.
SDS gel zymography
Zymography after SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) (Laemmli 1970) was performed as pub-
lished (Trachslin et al. 1999). Briefly, 0.1 % pig skin
gelatin (Merck) was added to the polyacrylamide (10 %)
solution before polymerization of the gel. E14.5 wild-type
mouse embryo heads were extracted in SDS sample buffer
(Laemmli 1970) (300 ll per head) and 7 ll extract was
loaded on the gel per lane. In control experiments, culture
medium conditioned by lipopolysaccharide-stimulated
human macrophages (10 ll per lane) was loaded instead.
After electrophoresis, the polyacrylamide gels were
washed four times for 15 min with 2.5 % Triton X-100,
10 mM Tris–HCl, pH 8.0, and four times for 5 min in
50 mM Tris–HCl, pH 8.0. Gels were then incubated in
gelatinase reaction buffer (see above) for 48 h at 37 C,
washed in distilled H2O for 10 min, stained with Coo-
massie Blue for 1 h, destained with 25 % isopropanol/
10 % acetic acid in water for 30 min, then destained with
10 % isopropanol/10 % acetic acid in water for 3 h and
photographed. To control for the specificity of the enzyme
reaction, incubation was also performed by adding one of
the above-mentioned metalloproteinase inhibitors to the
incubation buffer in the same concentrations to those used
for the ISZ experiments.
Results
In situ zymography with DQ-gelatin: optimization
and controls
In a first series of experiments, we tested various protocols
to optimize and validate in situ zymography with DQ-
gelatin on unfixed frontal cryosections from a defined
region of the E14.5 wild-type mouse head (Fig. 1a). We
obtained the best results by diluting DQ-gelatin (final
concentration 20 lg/ml) directly in zymography buffer and
then incubating unfixed cryosections with this working
solution for 3 h at 37 C (see ‘‘Materials and methods’’).
As reported previously (Sakakura et al. 2007), gelatinolytic
activity was observed prominently in the developing
mandibular bone and in Meckel’s cartilage. Interestingly,
on the same sections quite strong activity was also detected
as sharp profiles surrounding distinct epithelial structures,
such as the ducts of the salivary glands and the epithelial
fold that separates the tongue from the lower jaw region
(Fig. 1b).
Various controls were performed to confirm the speci-
ficity of the enzymatic reaction and hence of the observed
fluorescent image. First, the pattern of activity remained
unchanged when DQ-gelatin was not added directly to the
zymography buffer, but when instead the slides were pre-
coated with substrate before sections were adsorbed and
incubated with buffer (Fig. 1c). This confirmed that the
result obtained by directly adding DQ-gelatin to
Fig. 2 Influence of temperature and incubation time on development
of the fluorescent signal during DQ-gelatin in situ zymography.
Unfixed frontal cryosections of a E14.5 wild-type mouse head were
incubated with DQ-gelatin working solution (see ‘‘Materials and
methods’’) at either 4 C or 37 C for 0, 1.5, or 3 h, respectively. The
fluorescent signal increased with time and temperature, indicating that
it was due to an enzymatic reaction. Note also that apart from the
regions shown already in Fig. 1, gelatinolytic activity was detected in
the myotendinous insertion of the main tongue muscle (arrows). MB
mandibular bone, MC Meckel’s cartilage, TN tongue. Bar 200 lm
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zymography buffer cannot be attributed to differential
binding of the substrate to the section. However, we
stopped pursuing the precoating method because it yielded
a higher background fluorescence (Fig. 1c).
For a second control, the gelatinolytic reaction was
shown to be time dependent, since increased fluorescence
was observed with prolonged incubation time (0, 1:30,
3 h). Incubation at decreased temperature (4 C) showed a
reduction of fluorescence increase with time compared to
incubation at 37 C (Fig. 2). Both of these findings indicate
that the final result is due to an enzymatic reaction.
Furthermore, ISZ of serial sections showed that the
fluorescent signal was reduced when adding excess unla-
beled gelatin to the DQ-substrate solution (Supplementary
Fig. S1a, b). Incubation with zymography buffer alone
(Fig. S1c) did not give any signal. ISZ on paraformalde-
hyde-fixed sections also resulted in essentially no fluores-
cence (Fig. S1d).
The addition of various types of inhibitors to the
zymography buffer resulted in partial or complete inhibi-
tion of fluorescence generated by DQ-gelatin cleavage.
Comparison of Fig. 3a (control) with Fig. 3b shows that
inclusion of 0.2 % DMSO, which was used as carrier for
MMP-2/MMP-9 inhibitor (see below), did not inhibit the
gelatinolytic reaction. In contrast, 3 % DMSO strongly
suppressed the gelatinolytic reaction (Fig. 3c), as has been
published before (Xu et al. 2004). BiPS, a specific MMP-2/
MMP-9 inhibitor (50 lM), partially attenuated the reaction
in situ (Fig. 3d). On the other hand, 1 mM phenanthroline
(Fig. 3e), a potent Zn2? complexing agent and MMP
inhibitor, or 10 mM EDTA (Fig. 3f), a general divalent
cation chelator and metalloproteinase antagonist, almost
completely inhibited the gelatinolytic activity.
MMP-2 and MMP-9 detected in mouse embryo heads
by SDS-gel zymography
To identify the major proteases responsible for gelatino-
lytic activity in the developing mouse embryo head, we
subjected E14.5 craniofacial tissue extracts to gelatin
zymography on SDS-polyacrylamide gels (Fig. 4). Expect-
edly, in these extracts we could identify MMP-2 and
MMP-9 from their typical molecular weight on SDS gels
(72 and 92 kDa, respectively, for the unprocessed latent forms).
Both latent and smaller active forms were present for the
two enzymes. MMP-2 was the dominant gelatinase, while
MMP-9 was much less abundant (Fig. 4a). Incubation of
gels with zymography buffer containing various inhibitors
showed a similar pattern of inhibition to that observed in
zymography in situ. More specifically, 0.2 % DMSO did
not inhibit the gelatinolytic reaction, while 3 % DMSO
suppressed it. MMP-2/MMP-9 inhibitor BiPS (50 lM),
phenanthroline (1 mM) or EDTA (10 mM) appeared to
completely abolish the gelatinolytic activity of both
MMP-2 and MMP-9 (Fig. 4a). However, since MMP-9
activity is only weakly visible in E14.5 extracts, we wanted
Fig. 3 Effect of MMP inhibition on development of fluorescent
signal during DQ-gelatin in situ zymography. Unfixed frontal
cryosections of a E14.5 wild-type mouse head were incubated with
DQ-gelatin according to the standard procedure (see ‘‘Materials and
methods’’), without or with addition of inhibitors to the reaction
buffer. a Control without inhibitor. b Inclusion of 0.2 % DMSO (used
as carrier for MMP-2/MMP-9 inhibitor) did not inhibit the
gelatinolytic reaction. c In contrast, 3 % DMSO significantly
suppressed the gelatinolytic reaction. d Addition of a specific
MMP-2/MMP-9 inhibitor (BiPS; 50 lM), partially attenuated the
reaction. e General MMP inhibitors 1,10-phenanthroline (1 mM) and
f EDTA (10 mM) strongly suppressed the gelatinolytic activity. MB
mandibular bone, MC Meckel‘s cartilage, TN tongue. Bar 200 lm
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to confirm that the inhibitors used here indeed act on this
enzyme as well. Thus, we repeated SDS gel zymography
using macrophage cell culture supernatants where MMP-9
is more abundant, and this led to similar findings apart
from weak or no inhibition of MMP-9 by 3 % DMSO
(Fig. 4b).
Colocalization of gelatinolytic activity
with immunolabeling for MMPs
A major technical aim of this study was to combine, on the
same slide, immunolabeling with ISZ without compro-
mising the sensitivity of the latter method. Since ISZ with
DQ-gelatin is most sensitive when performed on unfixed
tissue sections (Clark et al. 2010), we developed a double-
labeling technique where zymography is done first,
immediately followed by brief fixation with cold acetone
and immunofluorescence labeling (see ‘‘Materials and
methods’’).
Using this technique, we first aimed at investigating the
relationship between MMP protein distribution and gela-
tinolytic activity (Fig. 5). This is an important issue
because the proenzymes need to be processed for acti-
vation; thus the distributions of latent and active gela-
tinases might differ. Using specific antibody, we found
that MMP-2 protein has an almost ubiquitous distribution
in the E14.5 mouse embryo head, although highest
expression is found in the developing bone marrow cavity
of the mandibular bone and in the perichondrium of
Meckel’s cartilage (Fig. 5b). Thus, whereas MMP-2
immunostaining showed perfect overlap with gelatinolytic
activity in bone cavities, latent MMP-2 appeared to be
enriched around Meckel’s cartilage where enzyme activity
was lower than in the cartilage proper. MMP-9 protein
has a more restricted expression, but is also highly
expressed in developing bone marrow where it overlaps
with the zymography pattern (Fig. 5d). MMP-9 immu-
noreactivity was evident in the perichondrium of Mec-
kel’s cartilage together with MMP-2, but was also
detected in the cartilage itself, and in smaller amounts
near other regions that presented gelatinolytic activity,
such as around the ducts of the salivary gland and the
epithelial fold separating the tongue from the lower jaw
region. MMP-9 was also highly expressed and colocalized
with activity at the myotendinous insertion of the tongue
skeletal muscle (Fig. 5d). Among other MMPs, collage-
nase 3 (MMP-13) is known to possess significant gela-
tinolytic activity in vitro (Knauper et al. 1997). Like for
the classical gelatinases, MMP-13 immunoreactivity was
very strong in the developing mandible, and prominent in
the perichondrium (but not the interior) of Meckel’s
cartilage. MMP-13 was weakly but ubiquitously detect-
able in the mesenchyme, with some enrichment at the
base of the tongue (Fig. 5f). We also tested an antibody to
MMP-14/MT1-MMP. This membrane-bound enzyme is
known to activate other MMPs, particularly MMP-2, and
itself possesses gelatinolytic activity (Evans and Itoh
2007). In addition to strong expression again in bone
cavities, MT1-MMP had a similar distribution as MMP-9,
with the exception of Meckel’s cartilage where it was
Fig. 4 Detection of MMP-2 and MMP-9 activity in extracts of E14.5
mouse embryo heads by SDS-gel zymography, and effect of
inhibitors. a E14.5 wild-type mouse head extracts were run on
10 % polyacrylamide-SDS gels containing 0.1 % gelatin. Gels were
washed, developed for zymography in the absence or presence of
inhibitors, and stained with Coomassie. Pro-MMP-9 (92 kDa), MMP-
9 (80 kDa), pro-MMP-2 (72 kDa), and MMP-2 (68 kDa) were
identified by their relative molecular weight on the gel. The control
(lane at left) revealed a significant amount of MMP-2 and less MMP-
9 activity in the developing mouse head. 1 mM phenanthroline,
10 mM EDTA, and 50 lM specific MMP-2/MMP-9 inhibitor (BiPS)
all suppressed gelatinolytic activity. 0.2 % DMSO did not signifi-
cantly inhibit MMP-2 activity while 3 % DMSO did. b Same as a,
except that macrophage conditioned medium (Macrophages) rich in
MMP-9 was run on an SDS-gel for zymography. Results were
identical to a except for 3 % DMSO, which barely inhibited MMP-9
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Fig. 5 Double labeling for gelatinolytic activity and MMPs in the
craniofacial region of the mouse embryo. Frontal cryosections of a
E14.5 wild-type mouse head were subjected to DQ-gelatin zymog-
raphy, followed by immunofluorescence labeling for MMPs on the
same section. In situ zymography and immunofluorescence labeling
for MMP-2 (a, b), MMP-9 (c, d), MMP-13/collagenase-3 (e, f), and
MT1-MMP/MMP-14 (g, h), respectively. Note extensive colocalization
of all four enzymes with strong gelatinolytic activity in the
developing bone marrow cavities of the mandibles. The epithelial
fold between the tongue and the lower jaw (arrowheads) and the
salivary gland ducts (arrows), as well as the myotendinous insertion
of the main tongue muscle (asterisks) are indicated. For more details,
see ‘‘Results’’. MB mandibular bone, MC Meckel‘s cartilage, TN
tongue. Bar 200 lm
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(like MMP-2) enriched in the perichondrium rather than
the cartilage proper (Fig. 5h). In summary, all four
enzymes showed perfect codistribution with gelatinolytic
activity in mandibular bone cavities, and partial overlap in
other regions as described in more detail below.
Gelatinolytic activity in basement membranes
of the mouse embryo head
In addition, we employed ISZ followed by immunohisto-
chemistry to associate gelatinolytic activity in situ with
specific extracellular matrix components and structures.
Double staining for enzymatic reaction and ECM proteins
on the same section revealed that tenascin-C was not
colocalized with gelatinolytic activity except partially in
developing mandibles (Fig. 6c, f). On the other hand,
strong fibronectin staining was found together with prom-
inent gelatinolysis in many regions, such as Meckel’s
cartilage, mandibles and salivary ducts (Fig. 6a, d). How-
ever, the overlap was not complete and differential staining
was observed. For example, the basement membrane
region of all larger blood vessels was intensely stained by
anti-fibronectin. Of these, however, the major lingual artery
was also brightly fluorescent after in situ zymography,
whereas the periphery of other vessels exhibited little
or no gelatinolytic activity (Fig. 6a, d). Laminin-111
immunostaining colocalized with gelatinolytic activity
around the ducts of the salivary gland (Fig. 6b, e). Since
laminin-111 is an integral component of embryonic base-
ment membranes, this finding demonstrates that active
MMPs must be closely associated with these structures in
certain anatomical regions. Most interestingly, gelatino-
lytic activity was also found in the laminin-positive base-
ment membrane of the oral epithelium, however, almost
exclusively around the fold that separates the tongue from
the lower jaw region, but barely in adjacent regions
(Fig. 6b, e). Gelatinolytic activity codistributed perfectly
with laminin immunostaining at the bottom of the epithelial
fold, but faded out more cranially in the basement mem-
brane (Fig. 7). This finding prompted us to re-examine
more closely the distribution of gelatinolytic activity and
MMP proteins in this specific region at a slightly later stage
(E15.5; Fig. 8). Results were very similar for E14.5 and
E15.5 apart from a moderate increase in both MMP activity
(Fig. 8a, d, g, j) and expression (Fig. 8b, e, h, k) at the later
stage. Antibody to MMP-2 profusely stained the entire
area, with some enrichment in the basement membrane
exhibiting gelatinolytic activity (Fig. 8a–c). Punctate
MMP-9 immunolabeling was observed in the mesenchyme
surrounding the epithelial fold as well as on the luminal
surface; some overlap with enzyme activity was visible
mainly in mesenchyme in close proximity to the basement
Fig. 6 Double labeling for gelatinolytic activity and extracellular
matrix proteins in the craniofacial region of the mouse embryo.
Frontal cryosections of a E14.5 wild-type mouse head were subjected
to DQ-gelatin zymography, followed by immunofluorescence labeling
for extracellular matrix proteins on the same section. a In situ
zymography and d immunofluorescence labeling for fibronectin,
respectively, revealed colocalization in Meckel’s cartilage, mandi-
bles, and salivary ducts. Note that certain larger blood vessels
exhibited both intense fibronectin staining and gelatinolytic activity
(arrows), whereas others were fibronectin-positive only (arrow-
heads). b In situ zymography and e immunofluorescence labeling for
laminin, respectively, showed colocalization of gelatinolytic activity
with basement membranes of the ducts of the salivary gland (arrows)
and the epithelial fold that separates the tongue from the lower jaw
region (arrowheads). c In situ zymography and f immunofluorescence
labeling for tenascin-C, respectively, revealed little codistribution.
MB mandibular bone, MC Meckel’s cartilage, TN tongue. Bar
200 lm
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membrane (Fig. 8d–f). MMP13 was associated with fibrillar
matrix around the epithelial fold, and was found to overlap
with gelatinolytic activity in the basement membrane as
evidenced by a thin yellow line in the merged image
(Fig. 8g–i). A quite precise codistribution between activ-
ity and immunostaining was found for MT1-MMP in the
mesenchyme in punctate and fibrillar structures, and at the
periphery of the positive basement membrane area
(Fig. 8j–l). Thus, MMP-2 and MMP-13 exhibit the clearest
overlap with gelatinolysis in the basement membrane of the
lingual fold, but the other two enzymes might contribute to
activity at this specific site as well.
Discussion
The importance of MMP-mediated extracellular matrix
remodeling for skeletal development is documented by
genetic studies. In humans, for example, inactivating
mutations in the Mmp2 gene cause Torg syndrome, which
is characterized by facial abnormalities and severe defor-
mations of the limbs (Zankl et al. 2007). Mice deficient
for Mmp2 (Mosig et al. 2007) (Egeblad et al. 2007), Mmp9
(Vu et al. 1998), Mmp13 (Stickens et al. 2004) and Mmp14
(MT1-MMP; Holmbeck et al. 1999) have various defects in
skeletal and craniofacial structures. Gelatinases and other
MMP enzymes are prominently expressed during cranio-
facial development in the mouse embryo, as shown by
immunolabeling (Chin and Werb 1997; Iamaroon et al.
1996). Two papers so far investigated actual MMP activity,
rather than protein distribution, in the developing mam-
malian head by ISZ. An early study used in situ film
zymography for the detection of gelatinolytic activity in the
developing craniofacial tissues of the embryonic day 18 rat
(Abiko et al. 1999). After overnight exposure, a strong
signal was observed in eyes, tongue, Meckel’s cartilage,
mandibles, and salivary glands, and a weaker signal in
association with oral and nasal epithelia. However due to
the inherent disadvantages of the film overlay technique
(see ‘‘Introduction’’), the poor resolution of the images did
not allow to assign gelatinolytic activity to specific cells or
extracellular structures. A more recent paper focused on the
development and resorption of Meckel’s cartilage by ISZ
with a DQ-gelatin/agarose overlay; immunocytochemistry
for MMPs was performed in parallel on consecutive sec-
tions (Sakakura et al. 2007). In the present study, we
investigated the in situ pattern of gelatinolytic activity in a
confined but informative region of the E14.5 embryo
mouse head using DQ-gelatin as substrate. We confirmed
earlier results, but in addition were able to identify gela-
tinolytic activity in specific minute structures such as cer-
tain basement membranes. Through a series of experiments
Fig. 7 Colocalization of gelatinolytic activity with specific basement
membranes. Double-labeling a by in situ zymography and b by
immunofluorescence staining for laminin of a frontal cryosection of a
E14.5 wild-type mouse head; c is the merged image. The close-up
image shows precise colocalization of gelatinolysis with epithelial
basement membranes of the ducts of the salivary gland (arrows) and
the epithelial fold separating the tongue from the lower jaw region
(arrowhead). However, note that laminin-positive basement mem-
branes of tongue (TN) muscle fibers are negative for gelatinolytic
activity. MC Meckel’s cartilage, TN tongue. Bar 50 lm
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we developed a convenient and effective method for
detecting gelatinolytic activity on unfixed cryostat sections,
which can be combined with subsequent immunofluores-
cence staining to localize the responsible enzymes and their
potential ECM substrates on the same section. To achieve
the highest possible sensitivity, zymography was
performed on unfixed cryosections first, followed by fixa-
tion in ice-cold acetone (which best preserves the ISZ
pattern as well as antigenicity), and then sections were
labeled with antibodies. In preliminary ISZ experiments,
we immobilized the DQ-gelatin substrate by coating it on
slides, before adsorbing the cryosections. However, based
Fig. 8 Partial overlap of MMP immunostaining with gelatinolytic
activity in the basement membrane of the lingual fold. Frontal
cryosections of a E15.5 wild-type mouse head were subjected to DQ-
gelatin zymography, followed by immunofluorescence labeling for
MMPs on the same section. In situ zymography (left row) and
immunofluorescence labeling (middle row) for MMP-2 (a–c), MMP-9
(d–f), MMP-13 (g–i) and MT1-MMP (j–l), respectively. Merged
images are shown at right (c, f, i, l). Note partial colocalization
(yellow color in merged images) primarily of MMP-2 (c) and MMP-
13 (i) with the basement membrane of the epithelial fold (lingual fold;
arrowheads) that separates the tongue (TN) from the lower jaw
region. For more details, see ‘‘Results’’. Bar 50 lm
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on published procedures (Clark et al. 2010; Nagel et al.
2004; Wang and Tsirka 2005) we later added DQ-gelatin
substrate directly to the enzyme buffer, which gave iden-
tical results but reduced background fluorescence. Of
course, with this simplified method the question arises as to
how the DQ-gelatin stays fixed in place after cleavage by
MMPs. It has been suggested that its fluorescent cleavage
products remain bound to the gelatinases (Clark et al.
2010). As an alternative (or an additional) possibility, we
presume that DQ-gelatin in solution binds to fibronectin,
which is present in high amounts and almost ubiquitously
in embryonic tissue (Chiquet et al. 1981), and which has
high affinity for gelatin (Ehrismann et al. 1981). This of
course raises the possibility that the fluorescence patterns
obtained by in situ zymography with soluble DQ-gelatin
(Clark et al. 2010; Nagel et al. 2004; Wang and Tsirka
2005; our results) are confounded by the underlying
fibronectin distribution in the tissue. Two of our observa-
tions indicate that this is not the case. First, as already
mentioned, in situ zymography with DQ-gelatin immobi-
lized on slides yielded the same fluorescence patterns as
seen with soluble substrate. Second, although there was
considerable overlap between fibronectin staining and
observed gelatinolytic activity, notable differences were
evident between the two patterns (see Fig. 6). Thus, our
findings indicate that also with the simplified ISZ method
using soluble substrate, the fluorescence pattern faithfully
reflects sites of gelatinolytic activity.
We used inhibitors of varying specificity in order to
define the source of gelatinolytic activity detected with ISZ
on our sections. EDTA, a general metalloproteinase
inhibitor, as well as phenanthroline, a more specific MMP
inhibitor, completely abolished the reaction both in ISZ
and SDS gel zymography. 3 % DMSO, which has been
shown to inhibit MMP-2 activity by disrupting interactions
between its collagen-binding domain and the substrate (Xu
et al. 2004), significantly attenuated the reaction in situ,
and almost completely inhibited MMP-2 on the SDS-gel
zymogram. On the other hand, MMP-9 activity was only
slightly reduced by 3 % DMSO on the gel. This finding,
combined with a certain degree of remaining activity in
situ particularly in bone, suggested that there is some
redundancy between the two major gelatinases in vivo, as
has been also shown by knockout gene studies (Bruni-
Cardoso et al. 2010; Lambert et al. 2003). The more spe-
cific MMP-2/MMP-9 inhibitor BiPS completely inhibited
the enzymatic reaction of the two major gelatinases in gel
zymography, but only partially suppressed gelatinolytic
activity in situ. Taken together, these results suggest
that part of the activity detected in situ originates also
from other MMPs, such as MT1-MMP, which has been
shown to degrade gelatin as well (Overall 2002). By
immunofluorescence, we therefore examined the localization
of MMP-2, MMP-9, MMP-13, and MT1-MMP proteins,
and compared it to gelatinolytic activity on the same sections.
The first two MMPs not only constitute the major pro-
teinases for the degradation of denatured fibrillar collagens,
but also cleave basement membrane and other minor col-
lagens, namely collagen types IV, V, and VII (Hibbs et al.
1987; Odaka et al. 2005; Overall 2002). Of the mammalian
collagenases, MMP-13 (collagenase-3) has been associated
with craniofacial development (Blavier et al. 2001) and is
known to cleave gelatin and other ECM components in
addition to fibrillar collagens (Knauper et al. 1997). MT1-
MMP is a major activator of pro-MMP-2, whereby the
synergistic action of the two metalloproteinases leads to
increased proteolytic activity (Kudo et al. 2007; Nishida
et al. 2008). Thus, these four molecules are likely to be
responsible for most of the gelatinolytic activity that was
detected through ISZ. As expected, our results confirmed
the presence of either MMP-2, MMP-9, MMP-13, or MT1-
MMP in and near several regions that presented gelatino-
lytic activity. All four MMP proteins overlapped precisely
with very strong gelatinolytic activity in the bone marrow
cavities of the developing mandibles. Both MMP-2 and -9
colocalized with activity in Meckel’s cartilage proper, but
staining for MMP-2 protein was even stronger in the
perichondrium where little activity was observed. This is a
clear example of divergence between enzyme distribution
and activity, either because MMP-2 in perichondrium
occurs mostly as proenzyme, or because the active form is
inhibited by endogenous antagonists e.g. TIMPs.
The distribution of three major ECM proteins, namely
fibronectin, laminin, and tenascin-C, was also tested by
immunofluorescence in combination with ISZ, because the
first two (but not tenascin-C) have been shown to be sub-
strates for MMP-2, MMP-9, and MT1-MMP, whereas
tenascin-C is cleaved only by MMP-13 (Butler and Overall
2009; Koshikawa et al. 2000; Overall 2002; Zamilpa et al.
2010). Indeed, our findings showed colocalization of gel-
atinolytic activity with fibronectin and laminin in several
regions, but not with tenascin-C except in mandibles. As
mentioned, the overlap between fibronectin staining and
enzyme activity was quite extensive. Interesting differ-
ences were observed especially for major blood vessels: the
walls of all vessels were brightly stained by anti-fibro-
nectin, but only a subset also exhibited strong gelatinolytic
activity. We do not know yet what characterizes these two
types of vessels, and the significance of the finding awaits
further studies. Perhaps even more interesting was the
detection of gelatinolytic activity in the basement mem-
brane of the oral epithelium, however, restricted to the site
where it folds back onto itself at the base of the tongue and
the lower jaw region. Co-staining with specific antibodies
showed that MMP-2 and MMP-13 were clearly overlap-
ping with gelatinolytic activity in the basement membrane
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at this site, whereas MMP-9 and MT1-MMP were more
peripherally associated. One might speculate that increased
extracellular matrix turnover is required at this site for
maintaining the epithelial fold (and hence the opening of
the oral cavity) during growth of the tongue and the
mandibles. The present findings, which are based on a
simple but sensitive high resolution method to colocalize
gelatinolytic activity with specific extracellular matrix
structures in the embryo, form the basis to test such a
hypothesis.
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